-
Foreign investors had pulled out Rs 9,659 crore in April after infusing money in the preceding six months, according to the depositories' data
-
The index consists of 25 Covid-stocks broadly categorised into five verticals of the healthcare industry — vaccine manufacturers, pharma companies, hospital chains, pathology laboratories and medical equipment manufacturers
-
Investment by mutual funds in equities will continue in coming months seeing the increase in user growths as multiple fintech players are entering into this space, says an industry expert
-
The metal and pharma sectors are likely to continue their bull run whereas in the short term, BFSI, FMCG and auto sectors are likely to see some short-covering
-
The benchmark equity index BSE Sensex surged 424 points, or 0.87%, to 49,206 during the week.
-
Axis Securities has recommended over 10 stocks that can deliver robust returns to investors in the long run
-
Cipla, Dr Reddy's Laboratories, L&T and Vedanta are scheduled to announce their Q4 results on May 14
-
The focus of RBI has been towards providing assistance to those requiring the most critical assistance
-
Metal stocks were the star of the day as the Nifty Metal ended 4.7% higher with NALCO (up 9.85%), NMDC (up 8.07), SAIL (up 8.04%), Tata Steel (up 7.5%)
-
East India’s share has increased from merely 7.7% in March 2020 to 13.2% in March 2021. In March 2021 alone 21,000 new registration came in from Barpeta & 15,000 from Dhubri districts of Assam